A California judge rejected a motion by Odwalla, Inc., and the Coca-Cola Co. to dismiss a lawsuit alleging that the companies relied on false and misleading labeling claims that suggest their products were made with juice instead of sugar.
Bipartisan legislation introduced in the Senate Feb. 15 would drop the current statutory requirement for FDA medical device establishment inspections to be conducted every two years and adopt a system of risk-based scheduling for such inspections.
Continuing its enforcement focus on manufacturers and distributors of dietary supplements, the FDA entered into a consent decree of permanent injunction with a Louisiana-based manufacturer and distributor of products that the agency said included unapproved and misbranded drugs as well as adulterated and misbranded supplements.
The Electronic Retailing Self-Regulation Program (ERSP), an investigative part of the advertising industry’s self-regulation system, determined Nutraceutical Wellness, LLC, can support some claims for Nutrafol, a hair re-growth supplement, but recommended the marketer modify or discontinue other claims.
The FDA Enforcement Letter Database is Thompson Information Services’ exclusive online database of FDA Warning Letters, Untitled Letters and Cyber Letters. The database also contains Determination Letters issued by the U.S. Department of Health and Human Services Office for Human Research Protections. Enforcement letters in the database are searchable by a specific date or a range of dates, letter recipient, product category, regulatory topic, alleged violation, product name, letter type, and other text. The advanced search function includes a set of tips to help you quickly find the information you need.
You must be a subscriber to access this information. If you are a subscriber, please login. Not Yet A Subscriber? Click here to register for a free trial or contact Client Services at 800-677-3789 to activate your subscription.